ALK-Abello A/S (AKBLF)
38.89
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
ALK-Abello Price : 38.89 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 09, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 08, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 05, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 04, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 03, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 02, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| Jun 01, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 29, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 28, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 27, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 26, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 22, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 21, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 20, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 19, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 0.000 |
| May 18, 2026 | 38.89 | 38.89 | 38.89 | 38.89 | 1.000 |
| May 15, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 14, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 13, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 12, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 11, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 08, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 07, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
| May 06, 2026 | 35.55 | 35.55 | 35.55 | 35.55 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 43.28 |
| H. Lundbeck A/S | 7.29 |
| AstraZeneca PLC | 181.45 |
| ANI Pharmaceuticals, Inc. | 81.76 |
| Corcept Therapeutics, Inc. | 81.72 |
Price Related Metrics
| PE Ratio | 43.30 |
| PS Ratio | 8.456 |
| PEG Ratio | 0.9034 |
| Price to Book Value | 8.508 |
| Price to Free Cash Flow | 30.20 |
| Earnings Yield | 2.31% |
| Market Cap | 8.617B |
| PEGY Ratio | 0.8913 |
| Operating PE Ratio | 31.61 |
| Normalized PE Ratio | 43.30 |